Rabbit anti Human FHL2

1: Nair SS, Guo Z, Mueller JM, Koochekpour S, Qiu Y, Tekmal RR, Schule R, Kung HJ, Kumar R, Vadlamudi RK. PELP1/MNAR enhances androgen receptor functions through LIM-only coactivator FHL2. Mol Endocrinol. 2006 Dec 27 2:Kudo LC, Karsten SL, Chen J, Levitt P, Geschwind DH. Genetic Analysis of Anterior-Posterior Expression Gradients in the Developing Mammalian Forebrain. Cereb Cortex. 2006 Dec 5; 3: Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, Schule R, Buettner R. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.Cancer Res. 2006 Dec 1;66(23):11341-7. 4: Campo-Fernandez B, Morandell D, Santer FR, Zwerschke W, Jansen-Durr P. Identification of the FHL2 Transcriptional Coactivator as a New Functional Target of the E7 Oncoprotein of Human Papillomavirus Type 16.J Virol. 2007 Jan;81(2):1027-32. Epub 2006 Nov 8. 5: Govoni KE, Baylink DJ, Chen J, Mohan S. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice. Calcif Tissue Int. 2006 Aug;79(2):112-7. Epub 2006 Aug 15. 6: Sun J, Yan G, Ren A, You B, Liao JK. FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1. Circ Res. 2006 Sep 1;99(5):468-76. Epub 2006 Aug 3.